Our initial focus is on delivering improved solutions to the following conditions, which represent more than $2 billion in market opportunity:

  • Opioid overdose

  • Anaphylaxis

  • Hypoglycemia


People with life threatening conditions need to know in an emergency that the person next to them with very minimal training will be able to deliver a life saving treatment. Aktivax delivers communities that peace-of-mind.



Aktivax is working to remedy the continuing failure of rescue auto-injectors, to meet the needs of the users. Our products address these problems by providing a combination of superior:


Drug stability



What makes Aktivax’s ARAI auto-injectors different?